unresectable 中文意思是什麼
unresectable
解釋
不可切除的-
Transcatheter arterial chemoembolization ( tace ) offers a good alternative choice and improves the survival in the treatment of unresectable hepatocellular carcinoma
摘要經導管動脈化學栓塞療法對于不能切除的肝細胞癌是一個很好的治療方式,而且能改善存活率。 -
Clinical analysis of 125 i implants on 23 patients with unresectable pancreatic carcinoma
放射粒子治療中晚期胰腺癌23例臨床分析 -
In recent 20 years, advances in muscle flap surgery and availability of chest reconstructive prosthesis have encouraged the surgeons to take an active attitude toward chest wall resection ; many " unresectable " lesions now have a chance to be resected and cured
近20餘年來,重建材料的發展和軟組織重建技術的進步讓外科醫生在胸壁切除時更為積極,胸壁重建取得了很大的進步,許多在過去「不可切除」的病變得到了治愈的機會。 -
There are reliability therapeutic effects in transvascular interventional therapy on unresectable liver cancer
摘要對于不能手術切除的肝臟惡性腫瘤,經血管途徑行介入治療可獲得可靠療效。 -
Yamada r, et al. hepatic artery embolization in 120 patients with unresectable hepatoma radiology 1983 ; 148 : 397
林貴等.肝癌的微血管結構和血供.中華放射學雜志, 1985 , 5 : 257 -
Materials and methods : one hundred fifty patients with unresectable hcc were treated with ( 90 ) y microspheres
材料和方法: 150例用90釔玻璃微球治療的不能切除性肝細胞癌患者。 -
Treatment of unresectable late carcinoma of the pancreas by gastric bypass and laparoscopic cholecystojejunostomy : report of 42 cases
不能切除的胰腺癌經腹腔鏡旁路手術42例報告 -
Clinical trial of concurrent low - dose chemotherapy plus radiation vs sequential chemoradiotherapy for unresectable stage non - small cell lung cancer
期非小細胞肺癌同期減量放化療與序貫放化療的臨床試驗 -
We report a case employing a right internal mammary artery tace for an unresectable hepatocellular carcinoma, afterwhich the right upper abdominal wall developed an erythematous change
我們報告一個病例在經右內乳動脈栓塞其肝細胞癌后出現右上腹壁缺血、皮膚發紅的現象。 -
Abstract : objective to eveluate the effects of combined intraoperative hepatic arterial chemoembolization ( hace ) and postoperative hyperfractional radiotherapy ( hrt ) for unresectable liver cancer
文摘:目的觀察術中肝動脈化學藥物栓塞聯合超分割放射治療不能切除肝癌的效果。 -
The introduction of imatinib therapy has resulted in a 5 - year survival rate of 52 % for patients with unresectable or metastatic gists, irrespective of the initial dose, he said
伊馬替尼療法的介入已經導致不可切除或者轉移性胃腸間質癌病人52 %的五年生存率,這是不考慮初始劑量的,他說。
分享友人